The following is a roundup of some of the latest scientific studies on the new coronavirus SARS-CoV-2 and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
Delaying second Pfizer/BioNTech dose boosts antibodies in elderly
Delaying the second dose of the Pfizer/BioNTech COVID-19 vaccine beyond the originally recommended three-week gap used by the companies in clinical trials appears to induce a stronger antibody response in the elderly, UK researchers found.
Shortly after the vaccine became available, UK health officials advised that the second dose should be given 12 weeks after the first to allow more people to get protected by a first d…
Keep on reading: Delayed 2nd Pfizer shot boosts antibodies in elderly; COVID-19 obesity risk higher for men